PTGS2 and Guillain-Barre syndrome: Interestingly, increased COX-2 protein and prostaglandin E2 (PGE2) end product levels were detected in sera from patients with GBS, thereby supporting the implication of this inflammatory pathway in GBS pathogenesis [21].